ENGN
enGene Holdings Inc. Common Stock
NASDAQ: ENGN · HEALTHCARE · BIOTECHNOLOGY
$7.27
+3.27% today
Updated 2026-04-30
Market cap
$535.25M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.25
Dividend yield
—
52W range
$3 – $12
Volume
0.4M
enGene Holdings Inc. Common Stock (ENGN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $-13.06M | $-15.98M | $-17.59M | $-24.74M | $-48.28M | $-99.24M |
| Capital expenditures | $192000.00 | $248000.00 | $153000.00 | $318000.00 | $925000.00 | $1.49M |
| Depreciation | $259000.00 | $272000.00 | $238000.00 | $175000.00 | $91000.00 | $-2.56M |
| Stock-based comp | $150000.00 | $435000.00 | $116000.00 | $3.45M | $5.32M | $9.65M |
| Free cash flow | $-13.25M | $-16.23M | $-17.75M | $-25.06M | $-49.21M | $-100.72M |
| Investing cash flow | $-192000.00 | $-247000.00 | $-153000.00 | $-318000.00 | $-125.95M | $-25.14M |
| Financing cash flow | $12.85M | $22.52M | $27.97M | $86.15M | $265.72M | $1.52M |
| Dividends paid | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — |